SYMLIN® (pramlintide acetate) injection is only available as the SymlinPen pen injector and comes in 2 dose forms: SymlinPen 60 and SymlinPen 120. SYMLIN dosage differs depending on whether the patient has type 1 or type 2 diabetes.

SYMLIN is indicated as an adjunctive treatment in adults with type 1 or type 2 diabetes who use mealtime insulin therapy and who have failed to achieve desired glucose control despite optimal insulin therapy.

Access dosing and administration information for SYMLIN in type 1 and type 2 diabetes using the buttons below.